found that the steady blocking of the XIAP in human colon carcinoma cell line Colo320 subcutaneous tumors led to the delayed tumor growth and also supported susceptibility to TRAIL exerted anti-tumor functions in vivo (42). This evidence concerns the gene XIAP and neoplasm.